Skip to main content
. 2018 Nov 2;119(10):1244–1251. doi: 10.1038/s41416-018-0230-7

Fig. 4.

Fig. 4

Boxplots showing the distribution of tumour budding counts by CMS subtype in the a AMC-AJCCII-90, b LUMC, c CAIRO, and d CAIRO2 cohort. p-Values from Wilcoxon Rank Sum Test indicate a significant association between higher budding counts and the CMS4 subtype in all cohorts